Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Cryptic insertion of KMT2A , a rare t(9;11) variant

Nada Assaf, Christine Terré

Blood (2021) 137 (13): 1843.

https://doi.org/10.1182/blood.2020010442

Published: 2021

Journal Articles

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

James B Smadbeck, Beth A Pitel, MA, Kathryn E. Pearce, Sarah H Johnson, MS, Nicole Hoppman, Rhett P. Ketterling, MD, Patricia Griepp, MD, Linda B Baughn, PhD, George Vasmatzis, PhD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 5212.

https://doi.org/10.1182/blood-2019-122440

Published: 2019

Journal Articles

Impact of 9q Deletions on the Classification in AML

Bettina Balk, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 3925.

https://doi.org/10.1182/blood.V130.Suppl_1.3925.3925

Published: 2017

Journal Articles

Differing Mutational Profiles of IgHV + and IgHV - Patients Revealed By Whole Genome Sequencing in Chronic Lymphocytic Leukaemia (CLL)

Kate Ridout, Reem Alsolami, Adam Burns, Dimitris Vavoulis, Pavlos Antoniou, Peter Hillmen, Samantha JL Knight, Anna Schuh

Blood (2016) 128 (22): 5590.

https://doi.org/10.1182/blood.V128.22.5590.5590

Published: 2016

Journal Articles

New Mutation in Chromosome 9 Associated with Familial Autosomal Recessive Macrothrombocytopenia

Shoshana Revel-Vilk, MD MSc, Ela Shai, PhD, Nivin Gashem, MSc, Esti Hyam, Galia Spectre, MD, Orly Elpeleg, MD, David Varon, MD

Blood (2014) 124 (21): 2776.

https://doi.org/10.1182/blood.V124.21.2776.2776

Published: 2014

Journal Articles

hnRNP K : A Tumor Suppressor or Oncogene?

Miguel Gallardo, PhD, Hun Ju Lee, MD, Carlos E. Bueso-Ramos, MD PhD, Xiaorui Zhang, Laura R. Pageon, Asha Multani, Inmaculada Rapado, Alfonso Quintás-Cardama, MD, Steven M. Kornblau, MD, Joaquin Martinez-Lopez, Sean M. Post, PhD

Blood (2014) 124 (21): 259.

https://doi.org/10.1182/blood.V124.21.259.259

Published: 2014

Journal Articles

A Translocation (9;22)(p24;q11.2) In a Patient With CML

Daniele Costa Abreu, MSc, Ana Paula Castilho, Bachelor, Vivian Dionísio Niewiadonski, Bachelor, Mauricio Drummond, M.D., Nelson Gaburo, PhD

Blood (2013) 122 (21): 5184.

https://doi.org/10.1182/blood.V122.21.5184.5184

Published: 2013

Journal Articles

GFI1B Mutation Causes a Platelet Function Defect With Reduced Alpha-Granule Content and Abnormal Aggregation Response

Christopher M Ward, MB, CHB, PhD, Marie-Christine Morel-Kopp, PhD, Qiang Chen, BMed MSc, Hai Po Liang, PhD, Ashley P. Ng, MBBS, BMedSc, PhD, FRACP, FRCPA, Andrew W. Roberts, MBBS, PhD, Melanie Bahlo, PhD, William s Stevenson, MBBS, PhD

Blood (2013) 122 (21): 566.

https://doi.org/10.1182/blood.V122.21.566.566

Published: 2013

Journal Articles

ETV6-ABL1 CML Like Disorder with Complex Translocation Involving Chromosome 9, 12 and 14

Sophie Auger, MD, Jean Baptiste Gaillard, MD, Thierry Lavabre-Bertrand, PhD, Sandrine Hayette, Philippe Quittet, MD, Daniel Donadio, MD, Carole Exbrayat, MD

Blood (2012) 120 (21): 4438.

https://doi.org/10.1182/blood.V120.21.4438.4438

Published: 2012

Journal Articles

Pilot Study of the Incidence of Constitutional Chromosomal Abnormalities in a Community Clinic Setting

Yi Kong Keung, MD, FACP, Lap-Ching Keung, Annie Yeung, PA-C, Eddie H Hu, MD, FACP

Blood (2011) 118 (21): 4913.

https://doi.org/10.1182/blood.V118.21.4913.4913

Published: 2011

Journal Articles

Ph: not bad at all

François Guilhot

Blood (2011) 117 (25): 6741–6742.

https://doi.org/10.1182/blood-2011-04-346650

Published: 2011

Journal Articles

Deletions of the Normal ABL1 at the Non-Translocated Chromosome 9 in CML Associated with TKI Resistance.

Anna Virgili, Diana Brazma, Dr, Colin Grace, PhD, Elisabeth P Nacheva, MD, PhD, FRCPath

Blood (2009) 114 (22): 3254.

https://doi.org/10.1182/blood.V114.22.3254.3254

Published: 2009

Journal Articles

BCL2A1 Is a Survival and Immortalization Factor for Primitive Hematopoietic Cells.

Jean-Yves Metais, PhD, Thomas Winkler, MD, Rodrigo T. Calado, MD-PhD, Cynthia E. Dunbar, MD

Blood (2009) 114 (22): 2957.

https://doi.org/10.1182/blood.V114.22.2957.2957

Published: 2009

Journal Articles

PAX5 Wild-Type without IKZF1 (Ikaros) Deletion Is Associated with Prolonged Disease-Free Survival and Low Rate of Cumulative Incidence of Relapse in Adult BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL): On Behalf of GIMEMA AL Working Party.

Blood (2009) 114 (22): 12.

https://doi.org/10.1182/blood.V114.22.12.12

Published: 2009

Journal Articles

INK4 Locus Deletion in Childhood Acute Lymphoblastic Leukemia (ChALL)-a Preliminary Clinical Evaluation

Anna Paisiou, Jr., Stefanos I Papadhimitriou, Nikolaos Tsagarakis, Jr., Vassilios Papadakis, MD, PhD, Nektaria Kentrou, Georgios Paterakis, Agapi Parcharidou, Georgios Androutsos, Konstantinos Tsitsikas, Ioannis Kostopoulos, Dimitris Pavlidis, Maria Georgaki, Sophia Polychronopoulou

Blood (2008) 112 (11): 4858.

https://doi.org/10.1182/blood.V112.11.4858.4858

Published: 2008

Journal Articles

Do Deletions in 9p Reflect Prognosis in Adult Precursor B-Cell ALL? a Multi-Centre Study of 381 Patients

Hareth Nahi, Bengt Smedmyr, Sr., Helene Hallböök, Hans Hagglund, MD, PhD

Blood (2008) 112 (11): 4865.

https://doi.org/10.1182/blood.V112.11.4865.4865

Published: 2008

Journal Articles

Integrative Analysis of Genomic Aberration and Gene Expression Suggests That MPD with Loss of Heterozygosity or Gain of Chromosome 9 Represents a Distinct Entity

Weijia Zhang, PhD, Benjamin L. Ebert, MD, DPhil, Windy Berkofsky-Fessler, PhD, Monica Buzzai, PhD, Yezhou Sun, MSc, Caixia Xi, MSc, Ross L Levine, MD, D. Gary Gilliland, MD, PhD, Jonathan D. Licht, MD

Blood (2008) 112 (11): 3735.

https://doi.org/10.1182/blood.V112.11.3735.3735

Published: 2008

Journal Articles

Prognostic Impact of Deletions of Derivative Chromosome 9 on Patients (PTS) with Chronic Myelogenous Leukemia (CML) in Chronic Phase Treated with Nilotinib or Dasatinib.

Alfonso Quintas-Cardama, MD, Hagop M. Kantarjian, MD, Susan O’Brien, M.D., Gautam Borthakur, Srdan Verstovsek, William Wierda, Jenny Shan, Jorge Cortes, MD

Blood (2008) 112 (11): 2110.

https://doi.org/10.1182/blood.V112.11.2110.2110

Published: 2008

Journal Articles

High Frequency of the JAK2 V617F Mutation in Patients with Trisomy of Chromosome 9.

Hossein Mossafa, III, PHD, Hamid Belaouni, II, MD, Veronique Saada, PHD, Christine Fourcade, Sr., MD, J. Pierre Hurst, Sr., MD, Driss Chaoui, III, MD

Blood (2008) 112 (11): 1749.

https://doi.org/10.1182/blood.V112.11.1749.1749

Published: 2008

Journal Articles

BCL2A1 Is A Survival and Immortalization Factor for Primitive Myeloid Hematopoietic Cells.

Jean-Yves Metais, PhD, Ashley E. Dunfee, Rodrigo T. Calado, MD, PhD, Cynthia E. Dunbar, MD

Blood (2007) 110 (11): 3365.

https://doi.org/10.1182/blood.V110.11.3365.3365

Published: 2007

NARROW

Cryptic insertion of KMT2A , a rare t(9;11) variant

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

Impact of 9q Deletions on the Classification in AML

Differing Mutational Profiles of IgHV + and IgHV - Patients Revealed By Whole Genome Sequencing in Chronic Lymphocytic Leukaemia (CLL)

New Mutation in Chromosome 9 Associated with Familial Autosomal Recessive Macrothrombocytopenia

hnRNP K : A Tumor Suppressor or Oncogene?

A Translocation (9;22)(p24;q11.2) In a Patient With CML

GFI1B Mutation Causes a Platelet Function Defect With Reduced Alpha-Granule Content and Abnormal Aggregation Response

ETV6-ABL1 CML Like Disorder with Complex Translocation Involving Chromosome 9, 12 and 14

Pilot Study of the Incidence of Constitutional Chromosomal Abnormalities in a Community Clinic Setting

Ph: not bad at all

Deletions of the Normal ABL1 at the Non-Translocated Chromosome 9 in CML Associated with TKI Resistance.

BCL2A1 Is a Survival and Immortalization Factor for Primitive Hematopoietic Cells.

PAX5 Wild-Type without IKZF1 (Ikaros) Deletion Is Associated with Prolonged Disease-Free Survival and Low Rate of Cumulative Incidence of Relapse in Adult BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL): On Behalf of GIMEMA AL Working Party.

INK4 Locus Deletion in Childhood Acute Lymphoblastic Leukemia (ChALL)-a Preliminary Clinical Evaluation

Do Deletions in 9p Reflect Prognosis in Adult Precursor B-Cell ALL? a Multi-Centre Study of 381 Patients

Integrative Analysis of Genomic Aberration and Gene Expression Suggests That MPD with Loss of Heterozygosity or Gain of Chromosome 9 Represents a Distinct Entity

Prognostic Impact of Deletions of Derivative Chromosome 9 on Patients (PTS) with Chronic Myelogenous Leukemia (CML) in Chronic Phase Treated with Nilotinib or Dasatinib.

High Frequency of the JAK2 V617F Mutation in Patients with Trisomy of Chromosome 9.

BCL2A1 Is A Survival and Immortalization Factor for Primitive Myeloid Hematopoietic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only